European collaboration on relative effectiveness assessments: What is needed to be successful?

Author:

Kleijnen Sarah,Toenders Wil,de Groot Folkert,Huic Mirjana,George Elisabeth,Wieseler Beate,Pavlovic Mira,Bucsics Anna,Siviero Paolo D.,van der Graaff Martin,Rdzany RafałORCID,Kristensen Finn Børlum,Goettsch Wim

Funder

European Union and the participating HTA organisations

Publisher

Elsevier BV

Subject

Health Policy

Reference22 articles.

1. Specialty pharmaceuticals: policy initiatives to improve assessment, pricing, prescription, and use;Robinson;Health Affairs,2014

2. Ensuring value for money in healthcare: the role of health technology assessment in the European Union Observatory studies series, no. 11;Sorenson,2008

3. Harmonization of evidence requirements for health technology assessment in reimbursement decision making;Hutton;International Journal of Technology Assessment in Health Care,2008

4. Relative effectiveness assessment of pharmaceuticals: similarities and differences in 29 jurisdictions;Kleijnen;Value in Health,2012

5. High level pharmaceutical forum 2005–2008. Conclusions and recommendations;European Commission Enterprise and Industry,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3